MSC NewsWire

Founded by Max Farndale 1947 - 2018
Friday, 19 August 2022 18:06
  • Home
    • About Us
    • Pricing
    • Global Presswire
    • Industry Organisations
  • News Sectors
    • Headlines Through Today
    • Environmental Talk
    • Out of The Beehive
    • Primary Sector Talk
    • Reporters Desk
    • The MSC NewsReel
    • MSCNetwork
    • FinTech Talk
    • The FactoryFloor Newsreel
    • Trade Talk
    • News Talk
    • Industry Talk
    • Technology Talk
    • Blockchain
    • Highlighted
    • The TravelDesk
      • TravelMedia
      • Sporting Tours
      • Holidays Tours Events + More
      • Airfares
      • Travel Enquiry Form
      • TravelBits
    • Travel Updates
    • The MSC TravelDesk Newsreel
    • Travel Talk
    • Travel Time
    • The Bottom Line
    • Regional News
    • News to Run Advice Form
    • World News
    • NewsDIRECT
    • MSCVoxPops
    • Press Releases
  • National Press Club
  • Contact Us

Creso Pharma launches product into New Zealand

  • font size decrease font size decrease font size increase font size increase font size
  • Print
  • Email

Listed cannabis company Creso Pharma is set to launch its chronic pain product into the New Zealand market after signing an agreement with a key distributor.

Creso will introduce its cannaQIX 50 product in New Zealand, a cannabidiol lozenge designed to support the management of chronic pain.

Dr Miri Halperin Wernli, Creso CEO and co-founder, says the company is excited to launch the product into the world-class health system in New Zealand market.

"We are really excited to introduce cannaQIX 50 to New Zealand with CB Distributors," says Wernli.

"For Creso, New Zealand is an important market as it forms part of its overall APAC strategy, a region where projections suggest 23 per cent of the worldwide spend on CBD products will take place by 2022."

"[CB Distributors] is a young and highly motivated company with a genuine passion for the benefits cannabis can deliver to patients. This is a perfect fit with Creso's own philosophy and we anticipate a very successful collaboration."

The launch in the New Zealand market marks the first launch of Creso's CBD product in the APAC region, a market which is projected to be worth over US$700 million in sales by 2022.

According to the UN, 13.4 per cent of adults in New Zealand use black-market cannabis for medical or recreational purposes. The NZ Ministry of Health has suggested up to 235,000 people use cannabis for medical purposes.

The NZ government changed regulations in 2017 to allow for prescription of CBD products by all medical practitioners, but cannabis is still a controlled drug in the country.

This latest announcement follows a successful launch of cannabQIX 10 in Switzerland and Lichtenstein, with further launches pending in the UK and the Netherlands.

Shares in Creso Pharma are up 4 per cent to $0.65 per share at 10.25am AEST.

  • Source: Business News Australia
Published in MEDICAL
Tagged under
  • Business
  • medical
  • news talk

Related items

  • Sir Bill English to be honoured by Victoria University of Wellington
  • Higher bank capital better for banking system and NZ
  • Plastics industry helps designers create easy-to-recycle packaging
  • Great Barrier unhappy with Auckland’s marine sludge plan
  • XE Update Friday 30 November, 2018
More in this category: « Give me skin! The NZ company growing new skin for burn victims MIT engineers create low-cost prosthetic foot that approximates natural gait »
back to top
May 01, 2018

GMP Pharmaceuticals announces general manager appointment

in BUSINESS
Jun 11, 2018

Scott Technology buys US manufacturer

in BUSINESS
Jun 27, 2018

Serious Fraud Office and Reserve Bank investigating CBL Insurance matters

in BUSINESS
Jul 16, 2018

LSG SkyChefs decision “important legal victory”

in BUSINESS
Mar 12, 2018

Caniwi Capital buys exposure to housing boom with Lancer Aluminium purchase 12 Mar 2018

in BUSINESS
Apr 16, 2018

Ellerston Capital, with interest in 5.1% Fletcher stake, sees builder as a turnaround story

in BUSINESS
Aug 06, 2018

Hawke's Bay Export Award winners

in BUSINESS
May 21, 2018

Fulton Hogan to buy Stevenson's construction materials unit for undisclosed sum

in BUSINESS

MSC NewsWire is a gathering place for information on the productive sector in New Zealand focusing on Manufacturing, Productive Engineering and Process Manufacturing

  • Home
  • Global Presswire
  • Industry Organisations
  • National Press Club
  • Disclaimer
  • About Us
  • Pricing
  • Sitemap
Copyright © 2022 MSC NewsWire. All Rights Reserved.
Site Built & Hosted by iSystems Limited
Top
Home